TEST

Thursday, 20 December 2012

GEIC deadline extended to 31st December



   
                                                                                           

GEIC

    GBioFin Entrepreneurship and Innovation Certificate
    NOW IT’S YOUR TURN TO BE THE NEXT KIRAN MAZUMDAR!!!!!!!!!!!


We come across many students who have lots of business ideas during their graduation days, about opening their own business and a dream of being the Boss /CEO of their own company. But with time, these ideas get cornered and a person ends up finding a good job or takes up higher studies etc, but very few have the courage to start their own venture.

This happens due to many reasons like
a) Lack of knowledge like about how to go into the business
b) Improper direction as to what are the requirements for starting a business 
c) No guidance or less courage to start their own venture.

GBioFin (Gate to Biotech Industries, Organizations and Foundations in India) proudly announces the launching of GEIC (GBioFin Entrepreneurship and Innovation Certificate), a program specialized for entrepreneurship learning.
GEIC is 3 months Online Program started for promoting Biotechnology and Life Sciences in Entrepreneurship field. GEIC aims to provide all the Information regarding Entrepreneurship, Innovation, Research, and Intellectual Property Rights and so on.

It’s a 3-month online course, in which we will give you a larger and a practical picture of the steps / requirements that you need to go through before starting your own venture.
This 3 month program  will give you an edge over other students. Usually, students do  this kind of course after graduating from college so getting this know-how at the college level will at least save 1.5 years of your life.

Programme Includes-
     1. Online Interactive Sessions
     2. Online best course material and module notes (based on patterns from Cambridge and Oxford)
     3. E-Copies of Quarterly Magazine(Biotech Rings) for all the registered  students.
     4. Launch of a student Educational Magazine (E-Copy) for GEIC enrolled Students(including Articles given as assignment for GEIC)
     5.  Interaction with the advisor assigned for the GEIC through email
     6. GEIC Certificate will be sent at the home addresses of each candidate.
     7. Entry in the GBioFin Events with Heavy Discount/ Free Entry in some cases
     8. Gate100 Online Study materials for all.

And many more…

Registration Fees= 1000 /-

To register for GEIC please visit our website www.biofin.net, all the information and details are provided on the homepage.

Contact us:-
Shah Vaibhav-   09769253423
Co-Founder GBioFin Biotechnology Services

read more

TATA First Dot Student Start-up Award


APPEAL

We have been nominated for Tata first dot Student Start-up Award    Powered by NEN
VOTE for us  ( GBioFin Biotechnology Services) at Tata first dot to BRING THE CHANGE

Get yourself registered  and VOTE for Biotech.
Remember "VOTE" is different from the "LIKE" option. So do cast your vote. AND BRING THE CHANGE !!!!!!!
3 Steps to Cast your VOTE :-
1)Click on the link http://tatafirstdot.com/nomination/gbiofin
2)Click on the Thumbs up Option
3)Sign Up and Like again on the FB Link ( confirmation link will be send to your email id)
4) After the Click on the confirmation link your will be able to CAST YOUR VOTE
5) After you VOTE , make sure your Vote is registered.
- Make sure you VOTE and not just Like 

We have got 4,195 members on Facebook group. We can win this. Please vote.

Come Join Us in our Movement to BRING THE CHANGE !!!!!!!

read more

CSIR UGC NET(Life Sciences)


This post is dedicated to all the NET aspirants who will be taking the test this Sunday i.e. the 23rd December 2012. 
We hope you are all geared up and ready to rock the test.

CSIR NET exam is really a tough one and thousands of aspirants desire to crack it. It needs a thorough preparation which you all must be done with by now and a well planned strategy for taking the exam.
Here in this post we will be providing you some tips about CSIR UGC NET.


1. The first suggestion to all is to keep a check on the CSIR HRDG website always, even after you have taken the exam.
For instance the timings of the exams was changed as given here.

2. Try doing a lot of question papers of the previous NET exams, as many as possible. This helps in improving your speed which is a crucial factor when one is attempting the questions in very limited time.
In addition to that, it helps in preparing a strategy which you are most likely to follow in your exam to manage your time between questions (not all questions need to be attempted) and obtain the maximum efficiency and as a consequence the maximum marks.

3. Work on your strong topics very exhaustively. Since only 15/20, 35/50 and 25/75 questions need to be done, it will help you to decide the questions quickly thus saving a lot of time. In other words you should have complete knowledge of the topic you are very good at.

4. Never answer the questions randomly. Answer only if you are sure of the answer.
Sometimes categorizing the questions into 3 categories, absolutely sure ones, doubtful ones and the ones with no idea; is helpful. This way you can attempt the first category and only if the required number of questions have not been attempted then only you should try the next category questions.

Last of all, GBioFin wishes "All the Best" to all the candidates.


Just for reference sake:
Syllabus change 
Some Books for reference :

1. Upkars CSIR-UGC/NET/JRF/SLET Life Sciences by Dr.A.P.Singh Kumar Pushkara
2. Truemans UGC-CSIR JRF/NET Life Sciences by Pramod Singh

read more

Wednesday, 19 December 2012

Designing Influenza Immunogen


Influenza HA is the primary target of neutralizing antibodies during infection, and its sequence undergoes genetic drift and shift in response to immune pressure. The receptor binding HA1 subunit of HA shows much higher sequence variability relative to the metastable, fusion-active HA2 subunit, presumably because neutralizing antibodies are primarily targeted against the former in natural infection. We have designed an HA2-based immunogen using a protein minimization approach that incorporates designed mutations to destabilize the low pH conformation of HA2. The resulting construct (HA6) was expressed in Escherichia coli and refolded from inclusion bodies. Biophysical studies and mutational analysis of the protein indicate that it is folded into the desired neutral pH conformation competent to bind the broadly neutralizing HA2 directed monoclonal 12D1, not the low pH conformation observed in previous studies. HA6 was highly immunogenic in mice and the mice were protected against lethal challenge by the homologous A/HK/68 mouse-adapted virus. An HA6-like construct from another H3 strain (A/Phil/2/82) also protected mice against A/HK/68 challenge. Regions included in HA6 are highly conserved within a subtype and are fairly well conserved within a clade. Targeting the highly conserved HA2 subunit with a bacterially produced immunogen is a vaccine strategy that may aid in pandemic preparedness.


Read the full study here.
A summary is given here.


read more

Sunday, 2 December 2012

Hiyoshi Internship Program 2013

Hiyoshi Corporation, Omihachiman, Japan and ABK-AOTS DOSOKAI, Tamilnadu Centre are jointly organizing two months stipendiary International Internship Program’2013 at Japan for three students from the Engineering Colleges / Universities of India.

The students can be from Biotechnology, Environmental Science & Chemical Engineering and they should have consistently scored 75% of marks throughout.

Preferences will be given to those students who are having knowledge in basic Japanese Language skill.


Students who are perusing Third Year of Engineering or 1st yr of post graduation can apply for this program

Terms & Conditions and Application Form for the Training at Hiyoshi Corporation, Japan is in below link.

Internship details

Application form



read more

Monday, 26 November 2012

Capturing living cells in micro pyramids

Cells moving into the pyramids
A field full of pyramids, but on a micro scale. Each of the pyramids hides a living cell. Thanks to 3D micro- and nano scale fabrication, promising new applications can be found. One of them is applying the micro pyramids for cell research: thanks to the open ‘walls’ of the pyramids, the cells interact. Scientists of the research institutes MESA+ and MIRA of the University of Twente in The Netherlands present this new technology and first applications in Small journal of the beginning of December.
Most of the cell studies take place in 2D: this is not a natural situation, because cells organize themselves in another way than in the human body. If you give the cells room to move in three dimensions, the natural situation is approached in a better way while capturing them in an array. This is possible in the ‘open pyramids’ fabricated in the NanoLab of the MESA+ Institute for Nanotechnology of the University of Twente.
Tiny corner remains filled
The cleanroom technology applied for this, has been discovered by coincidence and is now called ‘corner lithography’. If you join a number of flat silicon surface in a sharp corner, it is possible to deposit another material on them. After having removed the material, however, a small amount of material remains in the corner. This tiny tip can be used for an Atomic Force Microscope, or, in this case, for forming a micro pyramid.
Catching cells
Chondrocyte captured inside a micro pyramid, interacting with its neighbours
In cooperation with UT’s MIRA Institute for Biomedical Technology and Technical Medicine, the nanoscientists have explored the possibilities of applying the pyramids as ‘cages’ for cells. First experiments with polystyrene balls worked out well. The next experiments involved capturing chondrocytes, cells forming cartilage. Moved by capillary fluid flow, these cells automatically ‘fall’ into the pyramid through a hole at the bottom. Soon after they settle in their 3D cage, cells begin to interact with cells in adjacent pyramids. Changes in the phenotype of the cell can now be studied in a better way than in the usual 2D situation. It is therefore a promising tool to be used in for example tissue regeneration research.
read more

Thursday, 15 November 2012

Solving the mystery of ageing

Why do we get older? When do we die and why? Is there a life without ageing? For centuries, science has been fascinated by these questions. Now researchers from Kiel (Germany) have examined why the polyp Hydra is immortal – and unexpectedly discovered a link to ageing in humans. The study carried out by Kiel University together with the University Medical Center Schleswig-Holstein (UKSH) will be published this week in the Proceedings of the National Academy of Sciences of the United States of America (PNAS). It was funded by the German Research Foundation DFG.

Hydra – mysteriously immortal
The tiny freshwater polyp Hydra does not show any signs of ageing and is potentially immortal. There is a rather simple biological explanation for this: these animals exclusively reproduce by budding rather than by mating. A prerequisite for such vegetative-only reproduction is that each polyp contains stem cells capable of continuous proliferation. Without these stem cells, the animals could not reproduce any more. Due to its immortality, Hydra has been the subject of many studies regarding ageing processes for several years.

Ageing in humans
Caption:A gene sequence is injected into an embryo of Hydra.
Copyright/Foto: CAU/Wittlieb
Human longevity gene discovered in Hydra
„Surprisingly, our search for the gene that causes Hydra to be immortal led us to the so-called FoxO gene“, says Anna-Marei Böhm, PhD student and first author of the study. The FoxO gene exists in all animals and humans and has been known for years. However, until now it was not known why human stem cells become fewer and inactive with increasing age, which biochemical mechanisms are involved and if FoxO played a role in ageing. In order to find the gene, the research group isolated Hydra’s stem cells and then screened all of their genes.

Immortality mechanism of Hydra revealed
The Kiel research team examined FoxO in several genetically modified polyps: Hydra with normal FoxO, with inactive FoxO and with enhanced FoxO. The scientists were able to show that animals without FoxO possess significantly fewer stem cells. Interestingly, the immune system in animals with inactive FoxO also changes drastically. „Drastic changes of the immune system similar to those observed in Hydra are also known from elderly humans“, explains Philip Rosenstiel of the Institute of Clinical Molecular Biology at UKSH, whose research group contributed to the study.

FoxO makes human life longer, too
„Our research group demonstrated for the first time that there is a direct link between the FoxO gene and ageing“, says Thomas Bosch from the Zoological Institute of Kiel University, who led the Hydra study. Bosch continues: „ FoxO has been found to be particularly active in centenarians – people older than one hundred years – which is why we believe that FoxO plays a key role in ageing – not only in Hydra but also in humans“. However, the hypothesis cannot be verified on humans, as this would require a genetic manipulation of humans. Bosch stresses however that the current results are still a big step forward in explaining how humans age. Therefore the next step must be to study how the longevity gene FoxO works in Hydra, and how environmental factors influence FoxO activity.

Without stem cells we all die
Scientifically, the study has two major conclusions: On the one hand it confirms that the FoxO gene plays a decisive role in the maintenance of stem cells. It thus determines the life span of animals – from cnidarians to humans. On the other hand, the study shows that ageing and longevity of organisms really depend on two factors: the maintenance of stem cells and the maintenance of a functioning immune system.
source:http://www.uni-kiel.de/aktuell/pm/2012/2012-332-foxogen-e.shtml
read more

How Do Cells Tell Time? Scientists Develop Single-Cell Imaging to Watch the Cell Clock

A new way to visualize single-cell activity in living zebrafish embryos has allowed scientists to clarify how cells line up in the right place at the right time to receive signals about the next phase of their life.
Under normal circumstances in zebrafish embryos, cells oscillate in synchrony
with their neighbors as they prepare to make segments that later become
muscle and vertebrae. When a color map (top left corner) is used to indicate the
 phase of oscillation in each cell at any fixed snapshot of time, with cool colors
representing the peak of the gene activation wave and warm colors the lower
levels of activation, it is evident in the top image that neighboring cells are in a
similar phase, or transitioning smoothly to the next phase. However, in embryos
 lacking a powerful messaging system called Notch signaling, that synchrony is
lost. In the bottom map, cells in mutant embryos that lack the Notch signal are
oscillating, but the random assortment of colors without smooth transitions
 shows that Notch is required to synchronize the oscillations in neighboring cells.
Images courtesy of Ohio State University
Scientists developed the imaging tool in single living cells by fusing a protein defining the cells’ cyclical behavior to a yellow fluorescent protein that allows for visualization. Zebrafish embryos are already transparent, but with this closer microscopic look at the earliest stages of life, the researchers have answered two long-standing questions about how cells cooperate to form embryonic segments that later become muscle and vertebrae.
Though these scientists are looking at the molecular “clock” that defines the timing of embryonic segmentation, the findings increase understanding of cyclical behaviors in all types of cells at many developmental stages – including problem cells that cause cancer and other diseases. Understanding how to manipulate these clocks or the signals that control them could lead to new ways to treat certain human conditions, researchers say.
Embryonic cells go through oscillating cycles of high and low signal reception in the process of making segmented tissue, and gene activation by the groups of cells must remain synchronized for the segments to form properly. One of a handful of powerful messaging systems in all vertebrates is called the Notch signaling pathway, and its precise role in this oscillation and synchronization has been a mystery until now.
In this study, the researchers confirmed that the cells must receive the Notch signal to maintain synchronization with nearby cells and form segments that will become tissue, but the cells can activate their genes in oscillating patterns with or without the signal.
“For the first time, this nails it,” said Sharon Amacher, professor of molecular genetics at Ohio State University and lead author of the study. “This provides the data that cells with disabled Notch signaling can oscillate just fine, but what they can’t do is synchronize with their neighbors.”
The imaging also allowed Amacher and colleagues to determine that cell division, called mitosis, is not a random event as was once believed. Instead, division tends to occur when neighboring cells are at a low point of gene activation for signal reception – suggesting mitosis is not as “noisy,” or potentially disruptive, as it was previously assumed.
 The study is published in the November issue of the journal Developmental Cell.
Amacher’s work focuses on the creation of these tissue segments, called somites, in the mesoderm of zebrafish embryos – this region gives rise to the ribs, vertebrae and muscle in all vertebrates, including humans.
“This early process of segmentation is really important for patterning a lot of subsequent developmental events – the patterning of the nervous system and the vasculature, much of that depends on this clock ensuring that early development happens properly,” Amacher said.
Unlike the well-known 24-hour Circadian clock, however, the activities of cells at the earliest stages of development can occur within a matter of minutes – which makes their clocks very challenging to study.

Experts in tissue segmentation liken the oscillating cycle of gene activation and de-activation that cells go through before they form somites to the wave that fans perform in a stadium. According to the segmentation clock, genes are turned on, proteins are made, proteins then inhibit gene activation, and so on, and the pattern repeats until all necessary somites are formed. Neighbor cells must be in sync with each other just as sports fans in the same section must stand and sit at the same time to effectively form a wave.
Zebrafish somites form every 30 minutes, meaning that during any one cycle of the wave, a cell is engaged in making protein for only about five minutes. To generate the imaging tool, researchers linked a yellow fluorescent protein to a cyclic protein known to have a short lifespan. The resulting short-lived fluorescent fusion protein allowed Amacher and colleagues to look at single cells along with their neighbors to observe how they stayed synchronized as they did the wave.
Researchers in this field had previously thought that the Notch signaling pathway may be needed to start the clock in these cyclic genes, though conflicting data had shown that the clock could run without the signal.
Amacher’s imaging showed that, indeed, Notch was required only to maintain synchronization, but not to start the oscillating clock. She and colleagues tested this idea by combining the imaging tool with three mutant cell types with disabled Notch signals. Cells in all three mutants could oscillate, but not in a synchronized fashion, explaining how they failed to form segments in the way that cells receiving the Notch signal could.
Defects in Notch signaling are associated with human congenital developmental disorders characterized by malformed ribs and vertebrae, suggesting this work offers insight into potential therapies to prevent these defects.
The researchers next sought to determine whether cell division interrupted the synchrony needed for creation of the segments. Mitosis, occurring among 10 to 15 percent of embryonic cells at any one time, is considered a source of biological “noise” because when cells divide, they stop activating genes. If division were happening randomly, as previously thought, instead of in a pattern, the very cell division needed for organism growth could also disrupt clock synchrony, creating problems that segmenting organisms would have to overcome.
The study showed, however, that most cells divided when their neighbors were at a low point of gene activation – at the bottom of a wave – suggesting that cell division doesn’t occur at random. The study team noted that the two daughter cells created from a fresh division are more tightly synchronized with each other than are any other cell neighbors in the area.
Under normal conditions, these two daughters resynchronize with their neighbors in short order. In embryos lacking Notch signaling, newly divided daughters appeared as a pair of tightly synchronous cells in a largely asynchronous sea, showing that oscillation could resume without the signaling pathway. Without Notch, the daughter cells gradually drifted out of synchrony, becoming like their asynchronous neighbors.
Amacher said these findings could be incorporated into models of developmental cell behavior to further advance cell biology research.
“Most of our tissues and organs are not made up of the same types of cells. They have different jobs. So you don’t want them to respond identically to every signal; you want them to have different responses,” she said. “We need to understand systems like this that help cells not only interpret the signals in their environment, but do the right thing when they get that signal.”
source:http://researchnews.osu.edu/archive/cellclock.htm
read more

GBioFin Entrepreneurship and Innovation Certificate

GBioFin proudly announces the launching of GEIC (GBioFin Entrepreneurship and Innovation Certificate).

GEIC is 3 months Online Programme started for Promoting Biotechnology and Life-Sciences with its scope in Entrepreneurship.GEIC aims to provide all the Information regarding Entrepreneurship, Innovation, Research, Intellectual Property Rights and so on.

Program Includes-
1-Online Interactive Sessions
2-Online best course material and module notes (having comparison with Cambridge and Oxford) with assignments
3- Launch of a student Educational Magazine E-Copy for GEIC enrolled Students (including Articles given as assignment for GEIC)
4-Interaction with the advisors assigned for the GEIC through email
5-GEIC Certificate will be sent at the home addresses of each candidate through post
6-Student Membership free for 1 year worth Rs.350 which includes the following:-
  a) Free Access & heavy discounts in Honorable Programs like GECP, GATE100, where they will         get and entry free of cost
  b) Latest jobs updates and first preferences to them for the jobs referred by GBioFin
  c) Heavy discounts in the Conferences conducted in Association GBioFin
  d) Yearly Subscription of e-Magazine free worth Rs.250
And much more ……….

To register for GEIC please visit our website www.biofin.net or register at geic@biofin.net, the information will be provided there very soon …
read more

Tuesday, 13 November 2012

Jellyfish-inspired device that rapidly and efficiently captures cancer cells from blood samples could enable better patient monitoring

Cells traveling through a microfluidic device can be trapped
by strands of DNA (green).
Image: Suman Bose and Chong Shen
Tumor cells circulating in a patient’s bloodstream can yield a great deal of information on how a tumor is responding to treatment and what drugs might be more effective against it. But first, these rare cells have to be captured and isolated from the many other cells found in a blood sample.

Many scientists are now working on microfluidic devices that can isolate circulating tumor cells (CTCs), but most of these have two major limitations: It takes too long to process a sufficient amount of blood, and there is no good way to extract cancer cells for analysis after their capture.

A new device from researchers at MIT and Brigham and Women’s Hospital overcomes those obstacles. Inspired by the tentacles of a jellyfish, the team coated a microfluidic channel with long strands of DNA that grab specific proteins found on the surfaces of leukemia cells as they flow by. Using this strategy, the researchers achieved flow rates 10 times higher than existing devices — fast enough to make the systems practical for clinical use.

Using this technology, described in this week’s issue of the Proceedings of the National Academy of Sciences, doctors could monitor cancer patients to determine whether their treatment is working.

“If you had a rapid test that could tell you whether there are more or less of these cells over time, that would help to monitor the progression of therapy and progression of the disease,” says Jeff Karp, an associate professor of medicine at Harvard Medical School and co-director of the Center for Regenerative Therapeutics at Brigham and Women’s Hospital in Boston.

This type of device could also enable personalized treatments: Once cells are isolated from a patient, doctors could test different drugs on them to determine which are most effective.

DNA ‘tentacles’

The number of CTCs found in a milliliter of a particular patient’s blood can range from just a few to several thousand. To isolate those rare cells, researchers have tried building microfluidic channels dotted with antibodies specific to a protein found on the target cells. However, because the antibodies only extend tens of nanometers from the bottom of the channel, the capture of cells by the antibodies is slow.

To extend the reach of the capture molecules, Karp and Karnik’s team mimicked the tentacles of jellyfish, creating long strands of repeating DNA sequences. Those sequences, known as aptamers, target a protein found in large numbers on leukemia cells.

The DNA strands are attached to a microchannel with a herringbone pattern on its floor. Those patterned ridges cause the blood to swirl as it flows through the channel, improving the chances that individual cells will come into contact with the tentacles, which extend hundreds of microns into the channel. This allows the researchers to increase the rate of blood flow.

“Normally what happens at high flow rates is the cells don’t really come close to the surface, and it’s very challenging to capture the target cells,” Karnik says. “But this combination of these herringbone grooves to mix the solution and bring the cells into contact with surfaces, plus having aptamers that are sticking out into the solution, enables very high capture rates at very high flow rates.”

Flow rates in the new device are 10 times higher than those reported for previous devices, and the system can capture 60 to 80 percent of the target cells. In the current model, which measures 1 square centimeter, the flow rate is 1 milliliter per hour. By making the device larger, the researchers say they could boost the flow rate to 100 milliliters of blood per hour — fast enough to rapidly process the 10- to 20-milliliter samples that would be needed to get an accurate CTC count from an individual patient.

Because the “tentacles” are made of DNA, they can easily be cleaved with enzymes, freeing the captured cells for further analysis.

Peter Kuhn, an associate professor of cell biology at the Scripps Research Institute, says this technology is an interesting alternative to existing approaches to capture rare cells, adding that further testing is needed to validate the technology’s usefulness.

“This field needs many different avenues for rare-cell identification to be explored,” Kuhn says. “These technologies can provide the key enablers for studying disease in humans.”

Minimally invasive

Devices that capture CTCs could offer a better alternative to sampling bone marrow in determining whether cancer treatment is working in a leukemia patient.

“If one could improve the sensitivity of detection in blood, then this approach may enable a transition from isolating marrow to isolating blood, which is much less invasive and you can do it more often. It could change the paradigm for how residual disease is detected,” Karp says.

“The beauty of this technology is its versatility,” Zhao says. “You can easily modify the length and density of the DNA chains; you can include different sequences in the DNA to capture different types of cells.”

This feature makes it a platform technology that can be broadly applied in the clinic and research laboratories. For instance, another possible application is capturing fetal cells, which are very rare in a pregnant woman’s bloodstream. Analyzing these cells could help doctors perform prenatal diagnostic tests for a range of diseases using an approach that is far less invasive than amniocentesis.

The researchers are now working on adapting the DNA strands to target other molecules, such as receptors found on the surfaces of cells dislodged from solid tumors
source:http://web.mit.edu/newsoffice/2012/capturing-rare-cancer-cells-1112.html
read more